Copy
Newsletter April 4, 2020


Researching the Undiscovered Properties of Cannabinoids for the Treatment of Respiratory Infectious Diseases
 
Intro
 
You're probably in quarantine as most of us are! Good news, we are still working very hard for our shareholders. Our newsletter will keep you informed about our progress while you’re safe at home.
 
What’s happening
 
Just how will the coronavirus epidemic end? It’s a question you’ve probably wondered about multiple times during this period of quarantine and social distancing. If not, you likely wish things would just go back to normal.

The present outbreak of a coronavirus-associated acute respiratory disease called coronavirus disease 19 (COVID-19) is the third documented spillover of an animal coronavirus to humans in only two decades that has resulted in a major epidemic. We believe it will not be the last.

The population is now well aware: having breathing difficulties is one of the first symptoms to watch out for related to the coronavirus. "The immune response to the virus triggers an inflammatory reaction in the lungs of infected people. When this inflammation becomes too intense, it causes serious breathing problems. And these are the complications that can lead to death. Hence the importance of better understanding this inflammatory reaction so we can find a treatment.
 
This is what we are working on!

At Wuhan General Group, our research science team believes that the naturally occurring anti-inflammatory and immunomodulatory properties of plant-based cannabinoids require further examination. You might ask why? What does CBD have to do with COVID-19 or any other actuate respiratory infectious diseases?

Ask yourself, how does the virus affect you? Yes, the symptoms. What symptoms do all acute respiratory diseases have in common in severe cases that can result in death?  Pneumonia.

The inflammatory responses of respiratory viruses associated with Severe Acute Respiratory Symptom (SARS) and Middle East Respiratory Syndrome (MERS) and now COVID-19, in severe most cases is Pneumonia which results from the infection that inflames the air sacs (alveoli) in one or both lungs. The air sacs may fill with fluid or pus (purulent material), causing a cough with phlegm or pus, fever, chills, and difficulty in breathing.

Pneumonia

Pneumonia is an infection that causes inflammation in your lungs. The main causes of pneumonia are bacteria, fungi, parasites, or viruses. If the pneumonia is severe, the affected person is generally hospitalized. Oxygen therapy may be used if oxygen levels are low. In developing countries, and also among the very old, the very young and the chronically ill, pneumonia remains a leading cause of death.

In adults, viruses account for approximately a third and in children for about 15% of pneumonia cases. Commonly-implicated agents include rhinoviruses, coronaviruses, influenza virus, respiratory syncytial virus (RSV), adenovirus, and parainfluenza. Those with viral infections may be secondarily infected with the bacteria Streptococcus pneumoniae, Staphylococcus aureus, or Haemophilus influenzae, particularly when other health problems are present. Different viruses predominate at different periods of the year; during flu season, for example, influenza may account for over half of all viral cases. Outbreaks of other viruses also occasionally occur, including hantaviruses and coronavirus. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can also result in pneumonia. The severity of the condition is variable.[1]
 
We are investigating how cannabinoids can reduce inflammation, therefore, reduce the time and treat the rigorous symptoms of pneumonia faster.
 
Understanding exactly how the virus works on the lungs and the immune system will help develop the best treatments to help patients.
 
 
Cannabinoids: undiscovered anti-inflammatory and immunity booster

Medical cannabis throughout the literature and the medical community is known to possess anti-inflammatory and immunomodulatory properties - cannabinoids being the active ingredients that come from the cannabis plant.

Previous studies have shown that the plant cannabinoids like CBD, or CBG work in unison, instead of isolated doses like you find in CBD oil — demonstrate particular effectiveness in reducing inflammation. Other research has shown flavonoids in cannabis — the phytonutrients responsible for a plant’s colour and pigmentation — contain anti-inflammatory effects 30 times more powerful than aspirin.

On top of that, we know from a medical standpoint that these active ingredients have immunomodulatory properties, meaning that they augment and boost the immune system. We’ve seen this in diseases such as Crohn’s disease, rheumatoid arthritis and multiple sclerosis where medical cannabis functions as a naturally occurring immunomodulator.

For example, focusing on how cannabinoids affect HIV/AIDS patients. Researchers found that those who were cannabis users developed stronger immune systems and generated more T cells that kill HIV. But, the study’s authors wrote, “the mechanisms by which marijuana acts upon immune and neurocognitive functioning cannot be determined from the current study.”
 

Cannabinoids: targeting Respiratory Infectious Diseases Symptoms

 
Wuhan is deeply committed. The need is too great and we have to act now and conduct the science for present and future virus pandemics. We are not suggesting with the current available knowledge of medical cannabis that it is a possible prevention, treatment or cure for the coronavirus. However, plant cannabinoids have naturally occurring immunomodulatory and anti-inflammatory properties that could change the course of treating respiratory infectious diseases symptoms.
 
First responders, doctors, nurses and so many more are working countless hours to help us all. They don’t do it for glory, but because they feel they have a mission. Like everyone on the front line in the fight against COVID-19, our team feels it can make a difference. We all can do our part. Back to the ER for me. Stay calm, we will get through this.
 

 Sincerely,
 
 Dr. Anna                                       
 
 
Twitter Twitter
LinkedIn LinkedIn
Instagram Instagram
 
 

                     Wuhan General Group, Inc.  |  6500 Transcanada Hwy 400   |  Quebec, Canada H9R0A5

 

Copyright © 2020 Wuhan General Group or its affiliates. All rights reserved. Medspresso, the logo, and all other related logos are trademarks of Wuhan General Group Inc or its affiliates.

You've received this email because  you opted in via our website or have shown an interest in the past. If you wish to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

 

Email Marketing Powered by Mailchimp